MTOR and renal carcinoma: Together, our observations suggest a novel combination therapy using RAPA + Honokiol that can effectively inhibit c-Met-induced and Ras-mTOR-mediated pathway(s) to restrict renal cancer growth as well as the immune escape of tumor cells.